跳至主要内容
临床试验/NCT03791879
NCT03791879已完成不适用

The Analgesic Effectiveness and Safety of Upgraded Caudal Dexmedetomidine Doses in Pediatric Hypospadias Surgery.

Mansoura University1 个研究点 分布在 1 个国家目标入组 164 人开始时间: 2019年1月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
164
试验地点
1
主要终点
Time to (1st analgesic request objective pain score (OPS) ≥4)

研究概览

简要总结

Dexmedetomidine (DEXM) is a highly selective α2-adrenoceptor agonist that has been used increasingly in pediatric anesthesia. This prospective double blinded randomized comparative study is designed to evaluate the analgesic effect of caudal increasing doses of DEXM 0.5 , 1 , 1.5 , 2µg/kg combined with Levobupivacaine (Levob) 0.125% (ED95% =125%=least effective concentration) in providing pain relief over a 24-h period and lowest surgical stress peak. Study hypothesis: Levobupivacaine 0.125 %( ED95) combined with different increasing doses of dexamedatomedine >1 µg/kg could not add more analgesic & stress response obtundation outcome, but increase side effects (sedation and hemodynamic depression). The peak cortisol level during urology surgery was at the end of the 1st postoperative (PO) hour. Aim of the Study: To detect the optimal analgesic and safe caudal adjuvant DEXM dose associated with the least side effects& stress response modulation, guided by PO Cortisol peak difference in between the study groups during pediatric hypospadias surgery.

详细描述

Background: Dexmedetomidine (DEXM) is a highly selective α2-adrenoceptor agonist that has been used increasingly in pediatric anesthesia. This prospective double blinded randomized comparative study is designed to evaluate the analgesic effect of caudal increasing doses of DEXM 0.5 , 1 , 1.5 , 2µg/kg combined with Levobupivacaine (Levob) 0.125% (ED95% =125%=least effective concentration) in providing pain relief over a 24-h period and lowest surgical stress peak. Study hypothesis: Levobupivacaine 0.125 %( ED95) combined with different increasing doses of dexamedatomedine >1 µg/kg could not add more analgesic & stress response obtundation outcome, but increase side effects (sedation and hemodynamic depression).The peak cortisol level during urology surgery was at the end of the 1st postoperative (PO) hour. Aim of the Study: To detect the optimal analgesic and safe caudal adjuvant DEXM dose associated with the least side effects& stress response modulation, guided by PO Cortisol peak difference in between the study groups during pediatric hypospadias surgery.

Optimal effective dose defined as; the least caudal DEXM dose which produce the best analgesic outcome [least time to 1st analgesic request and lowest rescue analgesic dose (24Hs)] associated with the least stress response (cortisol PO. first One hour peak), least PO sedation, and hemodynamic stability IO. &PO. HR & MAP. The peak cortisol level during urology surgery was at the end of the 1st postoperative (PO) hour.

. Material & Methods A prospective randomized double blinded (drug injector and PO assessor) comparative study will be conducted in Mansoura university hospital after obtaining ethics committee approval and written informed parental consent 164 boys (age 1-6 years, ASA I) scheduled for hypospadias surgery. Exclusion criteria; (Operative time exceeding 3 hours, bodyweight >25kg, bleeding diathesis, infection at the site of block, pre-existing neurological or spinal disease or abnormalities of the sacrum, inability to palpate the sacral hiatus by anatomic landmark palpation technique) or those with a history of allergic reactions to local anesthetics were excluded from the study. Patients will fast for solids 6h and water and 2 hours before surgery. After Patient Preoperative preparation, General anesthesia induction, caudal block and caudal drug injection (Levob plus DEXM) bolus will be injected according to each group as follow;

  • Group A will take Caudal Levob 0. 125%+ DEXM 0.5µg/kg.
  • Group B will take Caudal Levob 0.125%+ DEXM 1µg/kg.
  • Group C will take Caudal Levob 0. 125%+ DEXM 1.5 µg/kg.
  • Group D will take Caudal Levob 0. 125%+ DEXM 2µg/kg.

The study outcomes recording:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
1 Year 至 8 Years(Child)
性别
Male
接受健康志愿者

入选标准

  • 164 boys (age 1-8 years, ASA I) scheduled for hypospadias surgery

排除标准

  • Operative time exceeding 3 hours, bodyweight >25kg, bleeding diathesis, infection at the site of block, pre-existing neurological or spinal disease or abnormalities of the sacrum, inability to palpate the sacral hiatus by anatomic landmark palpation technique) or those with a history of allergic reactions to local anesthetics were excluded from the study

研究组 & 干预措施

• Group A will take Caudal Levob 0. 125%+ DEXM 0.5µg/k

Active Comparator

干预措施: Caudal dexamedatomidine analgesia (Drug)

• Group B will take Caudal Levob 0.125%+ DEXM 1µg/kg.

Active Comparator

干预措施: Caudal dexamedatomidine analgesia (Drug)

• Group C will take Caudal Levob 0. 125%+ DEXM 1.5 µg/

Active Comparator

干预措施: Caudal dexamedatomidine analgesia (Drug)

• Group D will take Caudal Levob 0. 125%+ DEXM 2µg/kg.

Active Comparator

干预措施: Caudal dexamedatomidine analgesia (Drug)

结局指标

主要结局

Time to (1st analgesic request objective pain score (OPS) ≥4)

时间窗: Basal (0) till 24 hours.

time from full recovery till child express moderate pain OPS 4 and ask for the first analgesic dose

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mohamed Abd Latif Ghanim

Associate Professor os anesthesia ICU & Pain medicine.

Mansoura University

研究点 (1)

Loading locations...

相似试验